Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-15

FDA Approved: METRONIDAZOLE — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

The FDA approved a supplemental application for metronidazole from Baxter Healthcare Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METRONIDAZOLE (Metronidazole)

Snippet

SUPPL AP for METRONIDAZOLE (METRONIDAZOLE)